ImageAiD
Medical technology company developing a portable, point-of-care Doppler ultrasound platform for vascular diagnostics. Its handheld device captures tibial arterial waveforms and pairs them with AI-supported analysis to help identify peripheral artery disease earlier.
INDUSTRY
Medical Devices, Vascular Diagnostics
SECTOR
MedTech / Cardiovascular Health / Diagnostic AI
FOCUS
Peripheral Artery Disease, Early Detection, Vascular Screening
TECHNOLOGY
AI-Powered Vascular Diagnostics, Handheld Doppler Technology, Predictive Analytics
STAGE OF INVESTMENT
Seed
HEADQUARTERS
Scottsdale, AZ
WEBSITE
Peripheral artery disease is too often missed until it has already progressed. ImageAiD is building a practical, point-of-care way to detect it earlier, with a model designed for real-world adoption from the start.
Michael Shufeldt, MBA
Fund Manager
What they do.
ImageAiD is developing a portable, point-of-care Doppler ultrasound platform designed to detect peripheral artery disease earlier. Its handheld device captures tibial arterial waveforms noninvasively and pairs that data with AI-supported analysis to help clinicians identify PAD years before symptoms appear.
Why we invested.
What caught our attention was how much of the groundwork was already in place. ImageAiD combines strong founder-market fit, institutional support, reimbursement potential, and a product designed for practical adoption. Just as important, every scan can generate useful vascular data, creating a clinical dataset that could make the platform increasingly valuable as adoption grows.
Leadership
Josh Hanson
Founder & CEO
